Q3's Top 10 Deals Led By J&J's $42B Tylenol Owner Spinoff
By Al Barbarino · October 5, 2023, 2:30 PM EDT
The largest deal of the third quarter came by way of Johnson & Johnson's August split-off of Kenvue Inc., which valued the roughly 80% stake in the consumer health company at $42.2...
To view the full article, register now.